| 英文别名 |
xanthinol nicotinate;Xantinol Nicotinate;7-(2-hydroxy-3-((2-hydroxyethyl)methylamino)propyl)theophylline nicotinate;7-(2-Hydroxy-3-((2-hydroxyethyl)(methyl)amino)propyl)-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione nicotinate;7-[2-hydroxy-3-[2-hydroxyethyl(methyl)amino]propyl]-1,3-dimethylpurine-2,6-dione,pyridine-3-carboxylic acid;Nicotinic acid - 7-{2-hydroxy-3-[(2-hydroxyethyl)( methyl)amino]propyl}-1,3-dimethyl-3,7-dihydro-1H-p;Nicotinic acid - 7-{2-hydroxy-3-[(2-hydroxyethyl)-(methyl)amino]propyl}-1,3-dimethyl-3,7-dihydro-1H-p;Angioamin;Complamex;Complamin;Contamex;Landrina;Sadamine;Stenalgil;Teonicol;XANTHINOL NIACINATE;Xanthinolnicotinat;7-[2-Hydroxy-3-(2-hydroxyethyl-methyl-amino)propyl]-1,3-dimethyl-purine-2,6-dione pyridine-3-carboxylic acid;Xantinol Nicotinate（Xanthinol Nicotinate）;Xanthinol Nicotinate;(+/-)-7-(2-HYDROXY-3-((2-HYDROXYETHYL)METHYLAMINO)PROPYL)THEOPHYLLINE, COMPOUND WITH NICOTINIC ACID (1:1);SK 331A;Xantinoli nicotinas;SR-01000000242-4;HMS3371O12;7- 2-Hydroxy-3-((2-hydroxyethyl)methylamino)propyl theophylline, compound with nicotinic acid (1:1);437-74-1;HMS2230J12;SK 331 A;MLS006010909;UNII-8G60H12X2D;s4868;7-[2-Hydroxy-3-[(2-hydroxyethyl)methylamino]propyl]theophylline, compound with nicotinic acid (1:1);Xantinoli nicotinas [INN-Latin];Xanthinolium nicotinicum;7-{2-Hydroxy-3-((2-hydroxyethyl)methylamino)propyl}theophylline, compound with nicotinic acid (1:1);Complamin retard;SMR000058741;CCG-101097;NSC113217;Xantinol Nicotinate ,(S);HY-B1815;7-{2-Hydroxy-3-[(2-hydroxyethyl)methylamino]propyl}theophylline, compound with nicotinic acid (1:1);Xavin;Xanthinol niacinate (USAN);pyridine-3-carboxylic acid - 7-{2-hydroxy-3-[(2-hydroxyethyl)(methyl)amino]propyl}-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione (1:1);Opera_ID_260;Tox21_110866;DTXCID103743;MLS001424204;AS-11613;Nicotinate de xantinol;Vedrin;CHEMBL1560089;EINECS 207-115-7;HMS2052E09;Xantinolo nicotinato;Nicotinato de xantinol;Q5814478;3-Pyridinecarboxylic acid,7-dihydro-7-[2-hydroxy-3-[(2-hydroxyethyl)methylamino]propyl]-1,3-dimethyl-1H-purine-2,6-dione (1:1);Complamin (TN);Sadamin;AKOS005267237;NC00347;NCGC00021151-02;FT-0603393;Nicotinic acid compound with 7-(2-hydroxy-3-((2-hydroxyethyl)(methyl)amino)propyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione (1:1);7-[2-hydroxy-3-[2-hydroxyethyl(methyl)amino]propyl]-1,3-dimethylpurine-2,6-dione;pyridine-3-carboxylic acid;MLS000028609;AngioaminComplamin;MLS001148608;HMS3394E09;CS-0013860;Xanidil;CCG-269063;MFCD00058342;D06334;SCHEMBL121655;Xantinolo nicotinato [DCIT];E75972;{7-[2-Hydroxy-3-[(2-hydroxyethyl)methylamino]propyl]theophylline,} compound with nicotinic acid (1:1);3-Pyridinecarboxylic acid & {3,7-dihydro-7-[2-hydroxy-3-[(2-hydroxyethyl)methylamino]propyl]-1,} 3-dimethyl-1H-purine-2,6-dione (1:1);SR-01000000242;NS00080645;DTXSID0023743;A913692;Nicotinato de xantinol [INN-Spanish];Xantinol nicotinate [I... |
微信公众号
客服
